Authors
No matching authors found
Try adjusting your search criteria
Advertisement
Advertisement
Trending on CancerNetwork
1
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
2
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
3
Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer
4
Lenvatinib/Everolimus Beats Cabozantinib in Phase 2 RCC Study
5
